JIA Clinical Trial
Official title:
The iParent2Parent Program: Peer Mentoring for Parents of Children With Juvenile Idiopathic Arthritis
The iParent2Parent program matches parents of children living with arthritis with a trained parent mentor who will provide parents of children newly diagnosed with arthritis: practical coping advice and social support through shared lived experiences. This study will compare two groups of parents: those who are in the iParent2Parent program and those in the control group (no mentor).
Parents/primary caregiver of children with JIA are an often overlooked but essential member of their child's health care team. They are responsible for managing their child's treatment program, and act as advocates for their child to support positive adaptation to JIA and to learn self-management skills for the disease. This is in the context of managing the financial, logistical, emotional, and social demands of parenting in general. Within pediatric tertiary care centres, peer-support programs for parents of children with JIA are often limited or difficult to access. The iParent2Parent Program aims to fill this gap in services by offering a program of trained parent peer mentors who can provide practical coping advice, foster adaptive problem solving, and provide social support via shared lived experience. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05603286 -
Using Self-evaluation to Increase Visit Intervals in Juvenile Idiopathic Arthritis
|
N/A | |
Active, not recruiting |
NCT03816397 -
Adalimumab in JIA-associated Uveitis Stopping Trial
|
Phase 4 | |
Completed |
NCT00783510 -
Juvenile Idiopathic Arthritis (JIA) Registry
|
||
Not yet recruiting |
NCT05688358 -
Serum Interleukin - 17A in Juvenile Idiopathic Arthritis
|
||
Completed |
NCT06284616 -
JASP-1 for Children Recently Diagnosed and Their Parents
|
N/A |